NPPB is a potent inhibitor of chloride channel with an IC50 of 80nM for the short circuit current[1]. NPPB is commonly used in the study of epithelial ion transport mechanisms (such as cystic fibrosis and secretory diarrhea) and cardiovascular physiological regulation[2][3].
In vitro, treatment of human conjunctival fibroblasts (HConFs) with NPPB (100μM; 48h) inhibited proliferation, migration, and cell cycle progression, increased apoptosis, and reduced collagen I and fibronectin expression[4]. NPPB (30–120μM; 72h) inhibited the migration of adhesion fibroblasts (AFB) with an IC50 of 56.75μM, reduced cell proliferation in a concentration- and time-dependent manner, blocked volume-activated chloride currents (ICl, vol), and inhibited the regulatory volume decrease (RVD)[5].
In vivo, NPPB (20 and 40mg/kg; i.p.; 1–7h) increased mechanical and thermal hyperalgesia in crush injury-induced neuropathic pain in rats[6]. NPPB (0.1ml; 20mM; intra-arterial injection) prevented ET-1-induced vasoconstriction and reversed ET-1-induced histological alterations in the brainstem of rabbits[7].
References:
[1] Wangemann P, Wittner M, Di Stefano A, et al. Cl(-)-channel blockers in the thick ascending limb of the loop of Henle. Structure activity relationship. Pflugers Arch. 1986;407 Suppl 2:S128-S141.
[2] Lin WY, Sohma Y, Hwang TC. Synergistic Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Gating by Two Chemically Distinct Potentiators, Ivacaftor (VX-770) and 5-Nitro-2-(3-Phenylpropylamino) Benzoate. Mol Pharmacol. 2016;90(3):275-285.
[3] Diaz RJ, Losito VA, Mao GD, Ford MK, Backx PH, Wilson GJ. Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res. 1999;84(7):763-775.
[4] Sun L, Dong Y, Zhao J, et al. NPPB modulates apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling. Int J Mol Med. 2018;41(3):1331-1338.
[5] Zhong J, Qin Z, Yu H, et al. NPPB prevents postoperative peritoneal adhesion formation by blocking volume-activated Cl- current. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(3):501-510.
[6] Ramteke VD, Tandan SK, Kumar D, Aruna Devi R, Shukla MK, Ravi Prakash V. Increased hyperalgesia by 5-nitro-2, 3-(phenylpropylamino)-benzoic acid (NPPB), a chloride channel blocker in crush injury-induced neuropathic pain in rats. Pharmacol Biochem Behav. 2009;91(3):417-422.
[7] Dogulu F, Barun S, Emmez H, et al. Effect of a chloride channel inhibitor, 5-nitro-2- (3-phenylpropylamino)-benzoate, on endothelin-1 induced vasoconstriction in rabbit basilar artery. Turk Neurosurg. 2009;19(4):380-386.
NPPB是一种强效的氯通道抑制剂,对短路电流的IC50为80nM[1]。NPPB常用于上皮离子转运机制(如囊性纤维化、分泌性腹泻)和心血管生理调控研究[2][3]。
体外实验中,NPPB(100μM;48小时)处理抑制人结膜成纤维细胞(HConFs)的增殖、迁移和细胞周期进程,增加细胞凋亡,并降低胶原蛋白I和纤维连接蛋白的表达[4]。NPPB(30–120μM;72小时)抑制粘连成纤维细胞(AFB)的迁移,IC50为56.75μM,以浓度和时间依赖性方式减少细胞增殖,阻断体积激活的氯电流(ICl, vol),并抑制调节性体积减少(RVD)[5]。
体内实验中,NPPB(20和40mg/kg;i.p.;1-7小时)增加大鼠挤压损伤诱导的神经病理性疼痛的机械和热超敏反应[6]。NPPB(0.1ml;20mM;动脉内注射)预防兔脑基底动脉中ET-1诱导的血管收缩,并逆转ET-1诱导的脑干组织学改变[7]。
















